ArticlePloS one2026
High-intensity irreversible electroporation targeting intracellular structures enhance tumor ablation in lung cancer models.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to optimize irreversible electroporation (IRE) parameters to enhance intracellular injury, specifically targeting nuclear and mitochondrial structures that are insufficiently affected by conventional protocols. To address limitations of standard 1000 ~ 2500 V/cm clinical settings, we experimentally and computationally evaluated both low- and high-electric-field conditions and identified pulse parameters capable of safely achieving electric field strengths exceeding 4,000 V/cm, values that remain below the predicted arcing threshold for our electrode configuration while permitting effective intracellular electroporation. In vitro studies using A549 lung cancer cells demonstrated that high-field IRE markedly intensified oxidative stress, resulting in a 30-fold increase in hydrogen peroxide production and pronounced disruption of mitochondrial membrane potential. Transmission electron microscopy further confirmed severe ultrastructural injury, including plasma membrane rupture, nuclear membrane deformation, and complete loss of mitochondrial cristae, culminating in irreversible cell death. In vivo experiments corroborated these findings: high-field IRE produced extensive and uniform tumor ablation, whereas conventional lower field strengths generated only localized and partial damage. These results indicate that elevating electric-field intensity in IRE protocols can overcome the inherent limitations of traditional approaches by reliably inducing intracellular organelle damage, suppressing cellular repair pathways, and enhancing overall ablation completeness. Further studies are warranted to evaluate long-term safety and therapeutic durability of high-field IRE in vivo.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.